Public Health, Department of Social Medicine, Osaka University Graduate School of Medicine.
Department of Public Health, Kindai University Faculty of Medicine.
J Atheroscler Thromb. 2023 Mar 1;30(3):237-246. doi: 10.5551/jat.63378. Epub 2022 May 15.
Epidemiological evidence is extremely limited about high-sensitivity cardiac troponin T (hs-cTnT) and future coronary heart disease (CHD) events for the general population in countries with low mortality from CHD. Therefore, we investigated the association between hs-cTnT levels and the risk of incident CHD using a nested case-control study in a large Japanese cohort study.
The participants were residents of four Japanese communities in the Circulatory Risk in Communities Study (CIRCS). We obtained 120 cases (81 men and 39 women, aged 38-86 years at baseline) of first incident CHD and 240 controls matched by age, sex, communities, and blood sampling term. Serum hs-cTnT levels were measured using an electrochemiluminescence immunoassay with stored sera collected between 2001 and 2011. The median period between sampling at survey and CHD incidence was 2.0 (interquartile range, 0.9-3.7) years. After adjusting for conventional risk factors, the multivariable odds ratios (ORs) of CHD were calculated using conditional logistic regression analyses.
hs-cTnT ranged from ≤ 3 (assay detection limit) to 155 ng/L. Compared with the lowest quartile of hs-cTnT, multivariable ORs (95% confidence intervals) of CHD for the second, third, and highest quartiles were 1.30 (0.57-2.95), 2.48 (1.09-5.64), and 3.01 (1.27-7.12), respectively. Similar associations were observed after adjusting for estimated glomerular filtration, or after excluding matched groups, including people with chronic kidney disease.
Serum hs-cTnT could predict CHD in the Japanese general population. These findings implicate a benefit from monitoring hs-cTnT to predict CHD even among populations in countries with low mortality from CHD.
在冠心病死亡率较低的国家,有关高敏心肌肌钙蛋白 T(hs-cTnT)与普通人群未来冠心病(CHD)事件的流行病学证据极其有限。因此,我们通过一项大型日本队列研究中的巢式病例对照研究,调查了 hs-cTnT 水平与 CHD 发病风险之间的相关性。
参与者为社区心血管风险研究(CIRCS)中四个日本社区的居民。我们获得了 120 例(81 名男性和 39 名女性,基线时年龄为 38-86 岁)首次发生 CHD 的病例和 240 名按年龄、性别、社区和采血期相匹配的对照。使用电化学发光免疫分析法测量储存的血清 hs-cTnT 水平,血清采集时间为 2001 年至 2011 年。在调查时采样与 CHD 发病之间的中位时间为 2.0 年(四分位间距,0.9-3.7)。在调整了传统危险因素后,使用条件逻辑回归分析计算 CHD 的多变量比值比(OR)。
hs-cTnT 范围从≤3(检测限)到 155ng/L。与 hs-cTnT 的最低四分位数相比,hs-cTnT 的第二、第三和最高四分位数的 CHD 多变量 OR(95%置信区间)分别为 1.30(0.57-2.95)、2.48(1.09-5.64)和 3.01(1.27-7.12)。在调整估算肾小球滤过率或排除包括慢性肾脏病患者的匹配组后,也观察到类似的相关性。
血清 hs-cTnT 可预测日本普通人群中的 CHD。这些发现表明,即使在冠心病死亡率较低的国家,监测 hs-cTnT 以预测 CHD 也可能有益。